Paralemmin-1 was upregulated in androgen-independent relative to both androgen-dependent tumors and to normal controls in a mouse prostate model[9], and high levels of paralemmin-1 and paralemmin-2-AKAP2 expression were correlated with an invasive morphological phenotype of breast cancer cell lines[10]. Here, PALM is linked to breast cancer.